UOC

UBS O'Connor Portfolio holdings

AUM $920M
1-Year Est. Return 56.18%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+56.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.26B
AUM Growth
-$1.09B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
437
New
Increased
Reduced
Closed

Top Buys

1
+$447M
2
+$96.3M
3
+$67.2M
4
MRUS
Merus
MRUS
+$41.5M
5
LNT icon
Alliant Energy
LNT
+$19.6M

Top Sells

1
+$288M
2
+$227M
3
+$220M
4
CHX
ChampionX
CHX
+$187M
5
ANSS
Ansys
ANSS
+$173M

Sector Composition

1 Healthcare 22.95%
2 Financials 15.17%
3 Consumer Staples 13.02%
4 Technology 10.82%
5 Industrials 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMT icon
226
Walmart Inc
WMT
$995B
– –
-15,000
XBI icon
227
State Street SPDR S&P Biotech ETF
XBI
$8.74B
– –
0
XFOR icon
228
X4 Pharmaceuticals
XFOR
$392M
– –
-80,000
XLV icon
229
State Street Health Care Select Sector SPDR ETF
XLV
$38.5B
– –
0
XOP icon
230
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.32B
– –
0
XYF
231
X Financial
XYF
$179M
– –
-205,614
YMM icon
232
Full Truck Alliance
YMM
$9.04B
– –
-186,090
GEV icon
233
GE Vernova
GEV
$265B
– –
-1,680
FAASW
234
DELISTED
DigiAsia Corp Warrant
FAASW
– –
-135,667
BACQR
235
DELISTED
Inflection Point Acquisition Corp IV Right
BACQR
– –
-250,000
TTAN
236
ServiceTitan Inc
TTAN
$5.88B
– –
-50,000
PVLA
237
Palvella Therapeutics
PVLA
$1.82B
– –
-43,994
ONC
238
BeOne Medicines Ltd
ONC
$35.1B
– –
-9,377
XIFR
239
XPLR Infrastructure LP
XIFR
$970M
– –
0
XAGEW
240
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
– –
-371,250
CRWV
241
CoreWeave Inc
CRWV
$62.3B
– –
0
FLYY
242
DELISTED
Spirit Aviation Holdings, Inc.
FLYY
– –
-1,156,492
OYSEU
243
Oyster Enterprises II Acquisition Corp Units
OYSEU
– –
-100,000
BRR
244
ProCap Financial Inc
BRR
$174M
– –
-200,000
AAL icon
245
American Airlines Group
AAL
$8.16B
– –
0
AAP icon
246
Advance Auto Parts
AAP
$3.41B
– –
0
AAPL icon
247
Apple
AAPL
$3.89T
– –
0
ABBV icon
248
AbbVie
ABBV
$368B
– –
-13,297
ACAD icon
249
Acadia Pharmaceuticals
ACAD
$3.74B
– –
-43,000
ADPT icon
250
Adaptive Biotechnologies
ADPT
$2.25B
– –
-73,441
8 9
10
11 12